Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR004802)
Formula
CYP2C8 ...
SVG example
Reactant Montelukast sodium Product 25-OH Montelukast
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2C8 (CYP2C8) DME Info
Cytochrome P450 2C9 (CYP2C9) DME Info
Mephenytoin 4-hydroxylase (CYP2C19) DME Info
Cytochrome P450 3A4 (CYP3A4) DME Info
Cytochrome P450 3A5 (CYP3A5) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004796 Montelukast sodium Montelukast 1, 2-Diol Oxidation - Aliphatic hydroxylation Montelukast sodium [1]
MR004803 Montelukast sodium Montelukast ether glucuronide Unclear Montelukast sodium [2]
MR004798 Montelukast sodium Montelukast metabolite M1 Conjugation - O-glucuronidation Montelukast sodium [1], [2]
MR004799 Montelukast sodium Montelukast metabolite M2a/b Unclear Montelukast sodium [1]
MR004800 Montelukast sodium Montelukast metabolite M5a Oxidation - Hydrolyzationn Montelukast sodium [1], [2]
MR004801 Montelukast sodium Montelukast metabolite M5b Oxidation - Hydrolyzationn Montelukast sodium [1], [2]
References
1 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
2 In vitro metabolism of montelukast by cytochrome P450s and UDP-glucuronosyltransferases. Drug Metab Dispos. 2015 Dec;43(12):1905-16.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.